Clinical Trial Update: A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of Brensocatib in chronic rhinosinusitis without nasal polyps has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis Without Nasal Polyps

Drugs mentioned

• Brensocatib (brensocatib)

Snippet

Sponsor: Insmed Incorporated | Conditions: Chronic Rhinosinusitis Without Nasal Polyps | Phase 2 | Status: COMPLETED